Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design

The use of cohort multiple randomised controlled trials and epidemic crises https://bit.ly/39Obd4N

Detalles Bibliográficos
Autores principales: Porcher, Raphaël, Ravaud, Philippe, Resche-Rigon, Matthieu, Tharaux, Pierre-Louis, Mariette, Xavier, Hermine, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353064/
https://www.ncbi.nlm.nih.gov/pubmed/35896213
http://dx.doi.org/10.1183/13993003.01187-2022
_version_ 1784762791836516352
author Porcher, Raphaël
Ravaud, Philippe
Resche-Rigon, Matthieu
Tharaux, Pierre-Louis
Mariette, Xavier
Hermine, Olivier
author_facet Porcher, Raphaël
Ravaud, Philippe
Resche-Rigon, Matthieu
Tharaux, Pierre-Louis
Mariette, Xavier
Hermine, Olivier
author_sort Porcher, Raphaël
collection PubMed
description The use of cohort multiple randomised controlled trials and epidemic crises https://bit.ly/39Obd4N
format Online
Article
Text
id pubmed-9353064
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-93530642022-08-09 Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design Porcher, Raphaël Ravaud, Philippe Resche-Rigon, Matthieu Tharaux, Pierre-Louis Mariette, Xavier Hermine, Olivier Eur Respir J Correspondence The use of cohort multiple randomised controlled trials and epidemic crises https://bit.ly/39Obd4N European Respiratory Society 2022-09-15 /pmc/articles/PMC9353064/ /pubmed/35896213 http://dx.doi.org/10.1183/13993003.01187-2022 Text en Copyright ©The authors 2022. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Correspondence
Porcher, Raphaël
Ravaud, Philippe
Resche-Rigon, Matthieu
Tharaux, Pierre-Louis
Mariette, Xavier
Hermine, Olivier
Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design
title Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design
title_full Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design
title_fullStr Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design
title_full_unstemmed Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design
title_short Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design
title_sort reply: covid-19 drug research and the cohort multiple randomised controlled trial design
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353064/
https://www.ncbi.nlm.nih.gov/pubmed/35896213
http://dx.doi.org/10.1183/13993003.01187-2022
work_keys_str_mv AT porcherraphael replycovid19drugresearchandthecohortmultiplerandomisedcontrolledtrialdesign
AT ravaudphilippe replycovid19drugresearchandthecohortmultiplerandomisedcontrolledtrialdesign
AT rescherigonmatthieu replycovid19drugresearchandthecohortmultiplerandomisedcontrolledtrialdesign
AT tharauxpierrelouis replycovid19drugresearchandthecohortmultiplerandomisedcontrolledtrialdesign
AT mariettexavier replycovid19drugresearchandthecohortmultiplerandomisedcontrolledtrialdesign
AT hermineolivier replycovid19drugresearchandthecohortmultiplerandomisedcontrolledtrialdesign

Ejemplares similares